Physicians and scientists at the University of Minnesota have opened a new solid tumor cancer clinical trial and have treated their first patient with HCW9218, an injectable, bifunctional immunotherapeutic, developed by HCW ...
May 20, 2022
0
2
Researchers at Children's Hospital Los Angeles have shown that a select team of immune-system cells from patients with leukemia can be multiplied in the lab, creating an army of natural killer cells that can be used to destroy ...
Aug 19, 2014
0
0
A relatively newly discovered group of immune cells known as ILCs have been examined in detail in a new study published in the journal Nature Immunology. By analysing the gene expression in individual tonsil cells, scientists ...
Feb 15, 2016
0
4
UC San Francisco scientists have discovered a new way to control the immune system's 'natural killer' (NK) cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection. The ...
Jan 8, 2021
0
82
Researchers from The University of Texas MD Anderson Cancer Center showed that natural killer (NK) cells derived from donated umbilical cord blood, combined with a novel bispecific antibody known as AFM13 that targets CD16A ...
Apr 10, 2022
0
61
Stem cells derived from human amnion have for some time been considered promising for cell therapies because of their ease of access, ability to differentiate, and absence of ethical issues. Now, a Japanese research team ...
Jan 16, 2015
0
35
Preclinical research from The University of Texas MD Anderson Cancer Center finds that although glioblastoma stem cells (GSCs) can be targeted by natural killer (NK) cells, they are able to evade immune attack by releasing ...
Jun 17, 2021
0
8
Cancer cells have evolved multiple escape strategies to circumvent the body's immune defenses, such as the attack by natural killer (NK) cells that normally kill abnormal cells by releasing cytotoxic products. While studying ...
Oct 24, 2018
0
6
Natural killer cells (NK cells), play an important role in the body's defences against cancer and infections. Now, in a joint project, researchers at Lund University in Sweden, the University of Oxford, and Karolinska Institutet ...
Dec 14, 2018
0
4
The Wistar Institute's David B. Weiner and collaborators have engineered novel monoclonal antibodies that engage natural killer (NK) cells through a unique surface receptor that activates the immune system to fight against ...
Nov 1, 2023
0
21
